DSC Equity Fund – Healthcare A

Reference Data

ISIN AT0000A0XMM2
Valor Number 19994591
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 193.09 CHF 06.06.2025
Previous Price * 192.78 CHF 05.06.2025
52 Week High * 239.85 CHF 03.09.2024
52 Week Low * 188.45 CHF 22.04.2025
NAV * 193.09 CHF 06.06.2025
Issue Price * 198.89 CHF 06.06.2025
Redemption Price * 193.09 CHF 06.06.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 41,387,253
Unit/Share Assets *** 1,212,950
Trading Information SIX

Performance

YTD Performance -11.27% 30.12.2024
06.06.2025
1 month -3.09% 06.05.2025
06.06.2025
3 months -15.93% 06.03.2025
06.06.2025
6 months -12.95% 06.12.2024
06.06.2025
1 year -16.64% 06.06.2024
06.06.2025
2 years -10.56% 06.06.2023
06.06.2025
3 years -16.52% 07.06.2022
06.06.2025
5 years -11.15% 08.06.2020
06.06.2025

Tax Data

Equity Participation Rate in % 97.30
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 8.07%
Johnson & Johnson 6.91%
UnitedHealth Group Inc 5.23%
Abbott Laboratories 5.02%
AbbVie Inc 4.40%
Merck & Co Inc 3.95%
Sanofi SA 3.53%
AstraZeneca PLC 3.41%
Intuitive Surgical Inc 3.09%
Amgen Inc 2.82%
Last data update 30.04.2025

Cost / Risk

TER 1.53%
TER date 30.04.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.52%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)